BioprintingMedical Research

CD3D opens Europe’s largest 3D bioprinting cluster in Poland

Located in Lodz, Poland, the 3D Biocluster consists of 21 SKAFFOSYS bioprinters

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Polish 3D printer company CD3D has launched what it calls the first open 3D bioprinting cluster in Europe. The cluster is located in Lodz, Poland and consists of 21 SKAFFOSYS bioprinter units, which will be used to pursue research and development in the biomedical arena.

The new center, dubbed the 3D Biocluster, will be chiefly operated by CD3D’s medical division, CD3D Medical, with assistance from the Laboratory of Molecular and Nanostructured Biophysics at the Bionanopark, one of the largest lab complexes in Poland. The prolific site hosts a range of innovative projects relating to biotechnology and medicine.

CD3D Bioprinting Cluster

The 3D Biocluster will enable scientists at the Bionanopark to carry out biochemical, biological and molecular research by providing the ability to create three-dimensional structures on site and on demand. The bioprinter cluster will not only benefit the researchers at the facility, however, as the open nature of the 3D Biocluster means that external researchers and groups from Poland and abroad can commission the bioprinter units for R&D purposes.

The bioprinting cluster is made up of 21 Polish-made SKAFFOSYS bioprinters. The hardware is capable of printing scaffold structures out of hydrogel materials which support the growth of cells. The deposition-based technology uses a 5ml syringe to deposit the hydrogel onto a print bed. The bioprinter can also be used for bioplotting.

CD3D Bioprinting Cluster

The units installed as part of the cluster were specifically developed for CD3D Medical. In the future, the cluster could integrate more advanced 3D bioprinter models with new functionalities. The flexibility of the system enables it to be updated and to be modified to address new applications and challenges.

Overall, the expansive 3D Biocluster will serve the biomedical field for a range of applications, including studying new biocompatible materials, creating cell cultures, exploring regenerative medicine, testing new therapies on tissue models and even investigating new, alternative food sources.

CD3D hopes the bioprinting cluster will bring together research and industry partners to investigate a range of boundary pushing biomedical solutions. External parties seeking to leverage the bioprinter cluster will be supported by the expertise of CD3D Medical and the Laboratory of Molecular and Nanostructural Biophysics at the Bionanopark.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Tess Boissonneault

Tess Boissonneault is a Montreal-based content writer and editor with five years of experience covering the additive manufacturing world. She has a particular interest in amplifying the voices of women working within the industry and is an avid follower of the ever-evolving AM sector. Tess holds a master's degree in Media Studies from the University of Amsterdam.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!